Destiny Pharma (DEST) Rating Reiterated by FinnCap
Destiny Pharma (LON:DEST)‘s stock had its “corporate” rating restated by investment analysts at FinnCap in a note issued to investors on Wednesday.
DEST stock opened at GBX 89 ($1.16) on Wednesday. Destiny Pharma has a 1 year low of GBX 111 ($1.45) and a 1 year high of GBX 235 ($3.06).
Destiny Pharma Company Profile
Read More: Risk Tolerance and Your Investment Decisions
Receive News & Ratings for Destiny Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Destiny Pharma and related companies with MarketBeat.com's FREE daily email newsletter.